TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 84 filers reported holding TRANSENTERIX INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $41,000 | -65.3% | 18,218 | -10.5% | 0.00% | – |
Q3 2018 | $118,000 | +93.4% | 20,365 | +44.5% | 0.00% | – |
Q2 2018 | $61,000 | -11.6% | 14,095 | -13.5% | 0.00% | – |
Q1 2016 | $69,000 | +91.7% | 16,297 | +12.5% | 0.00% | – |
Q4 2015 | $36,000 | -47.1% | 14,486 | -51.7% | 0.00% | – |
Q3 2015 | $68,000 | -45.6% | 29,970 | -28.3% | 0.00% | – |
Q2 2015 | $125,000 | -25.6% | 41,817 | -27.2% | 0.00% | – |
Q1 2015 | $168,000 | -25.3% | 57,422 | -25.8% | 0.00% | – |
Q4 2014 | $225,000 | -9.3% | 77,390 | +35.9% | 0.00% | -100.0% |
Q3 2014 | $248,000 | – | 56,937 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |